Found 4 matching trials
Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older
PHASE3The purpose of this study is to evaluate the safety and immunogenicity of G...
Location
GSK Investigational Site
Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People
PHASE3The purpose of the study is to evaluate the safety of GSK Biologicals' infl...
Location
GSK Investigational Site
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly
PHASE3The objective of the study is to evaluate immunogenicity between different ...
Location
GSK Investigational Site
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
PHASE3The purpose of this study is to evaluate the efficacy of GlaxoSmithKline Bi...
Location
GSK Investigational Site